Pharvaris N.V.
PHVS
$14.00
$0.282.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -37.05M | -45.86M | -32.00M | -30.42M | -35.26M |
| Total Depreciation and Amortization | 97.00K | 47.90K | 73.90K | 72.00K | 71.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.48M | 10.76M | 272.70K | 2.27M | 8.15M |
| Change in Net Operating Assets | 4.18M | -1.52M | 1.86M | 1.77M | 1.40M |
| Cash from Operations | -37.26M | -36.57M | -29.80M | -26.31M | -25.63M |
| Capital Expenditure | -171.50K | -336.80K | -43.20K | -33.30K | -30.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -171.50K | -336.80K | -43.20K | -33.30K | -30.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -26.60K | -25.80K | -53.50K | -53.80K | -54.70K |
| Issuance of Common Stock | 592.70K | 1.02M | 443.00K | 189.80K | 278.71M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -1.00K | -66.10K | 659.00K | -16.92M |
| Cash from Financing | 603.50K | 1.09M | 348.10K | 863.10K | 281.77M |
| Foreign Exchange rate Adjustments | 10.75M | -6.38M | 2.83M | 627.50K | -5.41M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.08M | -42.20M | -26.66M | -24.85M | 250.71M |